ICBs |
Immune checkpoint blockers |
CTLA-4 |
Cytotoxic T lymphocyte-associated antigen 4 |
PD-1 |
Programmed cell death protein 1 |
PD-L1 |
Programmed cell death ligand 1 |
HBO |
Hyperbaric oxygen |
ECM |
Extracellular matrix |
HIF1α |
Hypoxia-inducible factor 1α |
MDSC |
Myeloid-derived suppressor cells |
VEGF |
Vascular endothelial growth factor |
PDGF |
Platelet-derived growth factor |
CTGF |
Connective tissue growth factor |
CTL |
Cytotoxic T lymphocyte |
EMT |
Epithelial-mesenchymal transition |
HCC |
Hepatocellular carcinoma cell |
LncRNA |
Long non-coding RNA |
Treg |
Regulatory T cells |
NK |
Natural killer |
CAFs |
Cancer-associated fibroblasts |
CLL |
Chronic lymphocytic leukemia |
ROS |
Reactive oxygen species |
M1 |
Macrophages1 |
M2 |
Macrophages2 |
EGFR |
Epidermal Growth Factor Receptor |
PI3K |
Phosphatidylinositol 3-kinase |
NF-κB |
Nuclear factor kappa-B |
IL |
Interleukin |
MAPK |
Mitogen-activated protein kinase |
DC |
Dendritic cells |
TCR |
T cell receptor |
MHC |
Major histocompatibility complex |
CD |
Cluster of differentiation |
VHL |
Von Hippel Lindau |
atm |
atmospheres |
ata |
atmospheres absolute |